Bart De Strooper

Bart De Strooper is scientific director of the UK-Dementia Research Institute since October 2016. He is professor of molecular medicine at the KU Leuven and VIB, Belgium and professor in dementia at the University College London, UK.  He received his M.D. in 1985 and Ph.D. in 1991 from KU Leuven. He worked as postdoctoral researcher in the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, in the laboratory of Carlos Dotti.

Honors and Awards

• 2002 Potamkin Award of the American Academy of Neurology
• 2003 Alois Alzheimer Award of the Deutscher Gesellschaft für Gerontopsychiatrie und psychotherapie
• 2005 the Joseph Maisin Prize for fundamental biomedical sciences, awarded by the FWO Flanders
• 2008 the Metlife Foundation Award for medical research
• 2018 the European Grand Prix for Research

Research Interest

Bart De Strooper ’s scientific work focuses on the understanding of the fundamental mechanisms that underlie Alzheimer’s and Parkinson’s disease. His major findings are the role of ADAM10 and presenilin/gamma-secretase 
in the proteolysis of the amyloid precursor protein and Notch, and he has worked on microRNA, mitochondria, and more recently on the role of the different brain cell types in the pathogenesis of Alzheimer’s Disease.